For research use only. Not for therapeutic Use.
KB130015（Cat No.:M103215）is an investigational antibody-drug conjugate (ADC) designed for the treatment of cancer. It consists of a monoclonal antibody that specifically targets a tumor-associated antigen, linked to a potent cytotoxic agent. The antibody component of KB130015 selectively binds to cancer cells, delivering the cytotoxic drug directly to the tumor site, thereby minimizing damage to healthy tissues. This targeted approach aims to improve the efficacy and safety profile of cancer treatment. KB130015 is currently under preclinical and clinical investigation to assess its potential in treating various types of solid tumors.
| CAS Number | 147030-48-6 |
| Synonyms | 2-[2,6-diiodo-4-[(2-methyl-1-benzofuran-3-yl)methyl]phenoxy]acetic acid |
| Molecular Formula | C18H14I2O4 |
| Purity | ≥95% |
| IUPAC Name | 2-[2,6-diiodo-4-[(2-methyl-1-benzofuran-3-yl)methyl]phenoxy]acetic acid |
| InChI | InChI=1S/C18H14I2O4/c1-10-13(12-4-2-3-5-16(12)24-10)6-11-7-14(19)18(15(20)8-11)23-9-17(21)22/h2-5,7-8H,6,9H2,1H3,(H,21,22) |
| InChIKey | OLIKCJUMYWSDIV-UHFFFAOYSA-N |
| SMILES | CC1=C(C2=CC=CC=C2O1)CC3=CC(=C(C(=C3)I)OCC(=O)O)I |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
